Female Pelvic Implants Market
Number of pages: 100 | Report Format: PDF | Published date: March 20, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 232.5 million |
|
Revenue Forecast in 2031 |
US$ 318.58 billion |
|
CAGR |
3.2% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Product Type, Indication, End-user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global female pelvic implants market was valued at US$ 232.5 million in 2022 and is expected to register a revenue CAGR of 3.2% to reach US$ 318.58 billion by 2031.
Female Pelvic Implants Market Fundamentals
Female pelvic implants are medical devices used to treat pelvic floor disorders in women, such as pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These disorders can occur due to various factors, such as childbirth, aging, obesity, and certain medical conditions. Female pelvic implants are designed to provide additional support to the pelvic organs and tissues, helping to restore normal function and improve quality of life.
Several types of female pelvic implants are available in the market, including vaginal mesh implants and vaginal slings. These devices are typically made of synthetic materials, such as polypropylene mesh, or biological materials, such as acellular dermal matrices. They are implanted through minimally invasive surgery and are customized to fit the individual needs of the patient.
[6756]
Female Pelvic Implants Market Dynamics
The global female pelvic implants market is primarily driven by the rising incidence of POP and SUI among women. These conditions are becoming more prevalent due to aging, obesity, and childbirth. For instance, according to the Association for Pelvic Organ Prolapse Support, there are around 300,000 POP surgeries in the U.S. annually. Advances in the design and materials used in pelvic implants have improved outcomes and reduced complications. Developing mesh materials that are less likely to cause adverse effects has increased the acceptance of these devices and thus boosted the global female pelvic implants market. Additionally, as awareness of pelvic floor disorders and treatment options grows, more women seek medical attention for these conditions. This leads to an increase in the number of pelvic implant procedures performed, fueling the revenue growth of the global female pelvic implants market.
However, while pelvic implants have effectively treated POP and SUI, they can also cause complications, such as infection, erosion, and pain. These adverse effects can discourage some women from considering these procedures. Furthermore, non-surgical treatments, such as pelvic floor muscle exercises and medication, are available for POPs and SUI. Some women may prefer these options over surgery, which can further limit the demand for pelvic implants. Additionally, the high cost of implants, side effects of available treatment, and tedious regulatory procedures impede the overall female pelvic implants market revenue growth.
Female Pelvic Implants Market Ecosystem
The global female pelvic implants market is analyzed from four perspectives: product type, indication, end-user, and region.
Female Pelvic Implants Market by Product Type
[85674]
Based on the product type, the global female pelvic implants market is segmented into vaginal mesh and vaginal sling/tape.
The vaginal mesh segment dominated the market with the principal revenue share in 2022, owing to its widespread usage in treating POP and SUI. Vaginal or transvaginal mesh is a female pelvic implant used to treat POP and SUI. The mesh is typically made of synthetic materials, such as polypropylene, and is implanted through minimally invasive surgery. Additionally, being minimally invasive, the recovery time for vaginal mesh surgery is often shorter than for other types of POP and SUI surgeries. They are designed to provide long-lasting support and may be more effective long-term than other surgical interventions. These factors contribute to the revenue growth of the vaginal mesh segment.
The vaginal sling segment dominated the market with the second-largest revenue share in 2022. Vaginal slings are female pelvic implants used to treat SUI. They are designed to provide support to the urethra and prevent urine leakage. Vaginal slings can be made of synthetic materials, such as polypropylene mesh, or biological materials, such as acellular dermal matrices. The most common vaginal slings are tension-free vaginal tape (TVT) and transobturator slings. TVT slings are implanted under the urethra and are anchored to the pubic bone or abdominal wall. Transobturator slings are implanted through the obturator foramen and are anchored to the pubic bone or ischial spine. Vaginal slings are typically implanted through minimally invasive surgery, such as laparoscopy or transvaginal mesh placement. The procedure can be performed on an outpatient basis and has a relatively short recovery time. These aspects contribute to the revenue growth of the vaginal mesh segment.
Female Pelvic Implants Market by Indication
Based on the indication, the global female pelvic implants market is segmented into pelvic organ prolapse and stress urinary incontinence.
The stress urinary incontinence segment accounted for the largest revenue share in the market in 2022, owing to its rising incidence. For instance, according to the Urology Care Foundation, one in three women suffer from SUI, and urinary incontinence rises with age. SUI is another common indication for female pelvic implants. SUI occurs when the muscles that support the bladder and urethra are weakened, leading to involuntary urine leakage during physical activity, such as coughing, sneezing, or exercising. It can be caused by various factors, including pregnancy and childbirth, menopause, obesity, and certain medical conditions that affect the nerves or muscles that control urination. Symptoms of SUI may include leaking urine during physical activity, feeling a sudden urge to urinate, and experiencing frequent urination. SUI can significantly impact a person's quality of life, causing embarrassment, social isolation, and decreased physical activity. Pelvic implants designed for SUI support the urethra and bladder neck, preventing leakage during physical activity. These devices are typically made of synthetic materials like mesh or tape and are implanted through minimally invasive surgery.
The pelvic organ prolapse segment dominated the market with the second-largest revenue share in 2022. POP is common among women, particularly those who have given birth, undergone pelvic surgery, or experienced menopause. POP occurs when the pelvic organs, such as the bladder, uterus, or rectum, drop from their normal positions and bulge into the vaginal canal. This can cause discomfort, pain, and incontinence. Symptoms of POP can include pressure or fullness in the pelvic region, a sensation of something protruding from the vagina, pain or discomfort during intercourse, and difficulty with urination or bowel movements. These factors contribute to the revenue growth of the POP segment.
Female Pelvic Implants Market by End-user
Based on the end-user, the global female pelvic implants market is segmented into hospitals, ambulatory surgical centers, and specialty clinics.
The hospitals segment dominated the market with the largest revenue share in 2022, attributed to being the primary location where pelvic implant procedures are performed. Many hospitals have specialized departments or centers for women's health, which may include pelvic floor disorder clinics. In addition to performing pelvic implant procedures, hospitals may also play a role in developing and testing new implant devices. This can include participating in clinical trials or collaborating with manufacturers on product development. Hospitals may also be involved in educating and training healthcare professionals who perform pelvic implant procedures. This can include offering continuing education courses or hosting training sessions for physicians, nurses, and other healthcare professionals. These facts contribute to the development of the hospitals segment.
The specialty clinics segment is expected to be the fastest-growing segment throughout the forecast period. Specialty clinics are typically dedicated to treating pelvic floor disorders, such as POP and SUI. They may also specialize in diagnosing and treating other conditions related to women's health. Specialty clinics may be staffed by a team of healthcare professionals, including gynecologists, urologists, and physical therapists trained in treating pelvic floor disorders. They may also have specialized equipment and facilities for evaluating and treating these conditions. In addition to offering pelvic implant procedures, specialty clinics may also provide non-surgical treatments for pelvic floor disorders, such as pelvic floor muscle exercises, biofeedback therapy, and medication. They may also offer patient education and support programs to help women manage their conditions and improve their quality of life. These factors contribute to the growth of the specialty clinics segment.
Female Pelvic Implants Market by Region
Geographically, the global female pelvic implants market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global female pelvic implants market with the largest revenue share in 2022, attributed to the presence of the key market players, rising incidence of POP and SUI, and substantial healthcare spending. Additionally, companies across the region are continuously involved in launching new and innovative products for pelvis-related issues, which is also helping in the growth of the market. For instance, in November 2022, CurvaFix, Inc., a developer of medical devices to treat fractures in curved bones, acquired 510(k) clearance (K222505) from the United States Food and Drug Administration (FDA) for its smaller-diameter CurvaFix IM Implant recommended for fixing of pelvic fractures. The novel 7.5mm device is intended to make surgery easier while providing robust, secure, curved fixation in smaller patients.
Female Pelvic Implants Market Competitive Landscape
The prominent players operating in the global female pelvic implants market are:
Female Pelvic Implants Market Strategic Developments
The global female pelvic implants market was valued at US$ 232.5 million in 2022.
The global female pelvic implants market is estimated to reach US$ 318.58 billion by 2031.
The female pelvic implants market is expected to register a revenue CAGR of 3.2% during the forecast period from 2023 to 2031.
The high cost of implants, side effects of available treatment, and tedious regulatory procedures restrict the global market revenue growth to its full potential.
Some prominent players operating in the global female pelvic implants market are Dipromed Srl, Caldera Medical, Betatech Medical, CurvaFix Inc., and C.R. Bard, Inc.
*Insights on financial performance are subject to the availability of information in the public domain